The State of CRISPR & Genome Editing 2025
It has been 20 years since the term “genome editing” first entered the scientific lexicon. The technology was transformed by the development of CRISPR gene editing in 2012. But the remarkable pace of progress in the first decade has hit some headwinds of late. In particular, the use of CRISPR as a clinical tool has progressed more slowly than anticipated, putting pressure on many gene editing companies to narrow their pipelines to conserve resources and highlighting the uphill challenge to deliver the potential of CRISPR to patients worldwide. Nevertheless, new discoveries are expanding the gene editing toolbox in novel and exciting directions.
In The State of CRISPR and Genome Editing virtual summit, GEN brings together an outstanding line-up of pioneers and practitioners in genome editing to provide a compelling and candid overview of the field. Attendees will hear about the latest scientific, technology, commercial and regulatory advances that will enable genome editing to unleash its full potential in the clinic and beyond.
Highlights of this summit include:
- A keynote lecture from Feng Zhang PhD (Broad Institute) on precision genome editing with and without CRISPR.
- Beth Shapiro PhD (Colossal Biosciences) discusses gene editing milestones, de-extinction and dire wolves.
- Fyodor Urnov PhD (Innovative Genomics Institute) on the path to achieving CRISPR cures for hundreds of rare genetic diseases.
- The state of cell and gene therapy in Africa with Julie Makani MD PhD (Tanzania) and Johnny Mahlangu (South Africa).
- A conversation on base editing and more with Alexis Komor PhD (UC San Diego) and Nicole Gaudelli PhD (Google Ventures).
- Neville Sanjana PhD (New York Genome Ctr) on new CRISPRs to probe the human non-coding genome.
- Breakout sessions from the summit sponsors.
Registration is free! Join us on June 11 for The State of CRISPR & Genome Editing.
Sponsored by:
